Top-News

CARIS LIFE SCIEN. A Aktie News

Aktie
WKN:  A41A14 ISIN:  US1421521071 US-Symbol:  CAI Branche:  Biotechnologie Land:  USA
24,80 €
+0,00 €
0,00%
08.12.25
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
35,66%
KGV
-
Index-Zuordnung
-

CARIS LIFE SCIEN. A News

04.12.25 - PR Newswire
Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium PR Newswire
02.12.25 - PR Newswire
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute
The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer Institute PR Newswire
21.11.25 - PR Newswire
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class PR Newswire
17.11.25 - PR Newswire
Caris Life Sciences to Attend Q4 2025 Investor Conferences
Caris Life Sciences to Attend Q4 2025 Investor Conferences PR Newswire
05.11.25 - PR Newswire
Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance PR Newswire
29.10.25 - PR Newswire
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response PR Newswire
23.10.25 - PR Newswire
Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025
Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025 PR Newswire
14.10.25 - PR Newswire
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025 PR Newswire
15.08.25 - PR Newswire
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek®
Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-​Approved MI Cancer Seek® PR Newswire
13.08.25 - PR Newswire
New Study from Caris Life Sciences Validates Optimal Sequencing in Informing Therapy Choices for Breast Cancer Subgroups
New Study from Caris Life Sciences Validates Optimal Sequencing in Informing Therapy Choices for Breast Cancer Subgroups PR Newswire
23.07.25 - PR Newswire
Caris Life Sciences to Report Second Quarter 2025 Financial Results on August 12, 2025
Caris Life Sciences to Report Second Quarter 2025 Financial Results on August 12, 2025 PR Newswire
22.07.25 - PR Newswire
Caris Life Sciences Validates and Extends Findings on Tumor-Infiltrating Clonal Hematopoiesis
Caris Life Sciences Validates and Extends Findings on Tumor-​Infiltrating Clonal Hematopoiesis PR Newswire
08.07.25 - PR Newswire
Caris Life Sciences Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure® Blood-Based Assay for Multi-Cancer Early Detection, Minimal Residual Disease and Therapy Selection
Caris Life Sciences Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure® Blood-​Based Assay for Multi-​Cancer Early Detection, Minimal Residual ...

Newssuche

Videos

newspaper
08.12.25 -2,30%
Technical Trading: Die besten 3 Tage
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »